For the quarter ending 2025-09-30, ACNT had -$2,437K decrease in cash & cash equivalents over the period. $695K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Operating Segments-Specialty Chemicals Segment | 5,840 | - |
| Corporate Non Segment | 0 | - |
| Gross profit | 13,773 | - |
| Selling, general and administrative expense | 17,567 | - |
| Acquisition costs and other | 665 | - |
| Operating Segments-Specialty Chemicals Segment | 0 | - |
| Corporate Non Segment | 0 | - |
| Asset impairments | 0 | - |
| Operating Segments-Specialty Chemicals Segment | 0 | - |
| Corporate Non Segment | 0 | - |
| Gain on lease modification | 544 | - |
| Interest expense (income), net | -347 | - |
| Operating Segments-Specialty Chemicals Segment | 0 | - |
| Corporate Non Segment | 57 | - |
| Income taxes | -32 | - |
| Operating Segments-Specialty Chemicals Segment | 0 | - |
| Corporate Non Segment | 296 | - |
| Other expense (income) | 296 | - |
| Net loss from continuing operations | -124 | -4,453 |
| Depreciation expense | 854 | 1,870 |
| Amortization expense | 153 | 306 |
| Amortization of debt issuance costs | 38 | 179 |
| Asset impairments | 0 | 1,622 |
| Deferred income taxes | 58 | -90 |
| (reduction of) provision for losses on accounts receivable | 18 | -506 |
| Non-cash lease expense | 86 | -1 |
| Stock-based compensation expense | 290 | 222 |
| Accounts receivable and advances | 302 | 4,908 |
| Inventories | 511 | 939 |
| Other assets and liabilities | -420 | 1,937 |
| Accounts payable | 177 | -1,712 |
| Accrued expenses | 354 | 1,387 |
| Accrued income taxes | -138 | 19 |
| Net cash (used in) provided by operating activities - continuing operations | 1,373 | -8,941 |
| Net cash provided by operating activities - discontinued operations | -62 | 6,845 |
| Net cash (used in) provided by operating activities | 1,311 | -2,096 |
| Purchases of property, plant and equipment | 616 | 466 |
| Net cash used in investing activities - continuing operations | -616 | -466 |
| Net cash provided by investing activities - discontinued operations | -1,900 | 54,425 |
| Net cash provided by investing activities | -2,516 | 53,959 |
| Borrowings from credit facilities | 24,800 | 89,670 |
| Proceeds from note payable | 0 | 1,085 |
| Payments on credit facilities | 24,800 | 89,670 |
| Payments on note payable | 326 | 370 |
| Principal payments on finance lease obligations | 75 | 144 |
| Repurchase of common stock | 831 | 8,044 |
| Net cash used in financing activities - continuing operations | -1,232 | -7,473 |
| Net cash used in financing activities - discontinued operations | 0 | -19 |
| Net cash used in financing activities | -1,232 | -7,492 |
| Increase in cash and cash equivalents | -2,437 | 44,371 |
| Cash and cash equivalents at beginning of period | 16,108 | - |
| Cash and cash equivalents at end of period | 58,042 | - |
ASCENT INDUSTRIES CO. (ACNT)
ASCENT INDUSTRIES CO. (ACNT)